Ubs Group Ag Nexalin Technology, Inc. Call Options Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NXL
# of Institutions
7Shares Held
102KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA38.9KShares$48,1930.0% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY38.4KShares$47,6320.0% of portfolio
-
Jane Street Group, LLC New York, NY11.3KShares$14,0230.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY9.08KShares$11,2570.0% of portfolio
-
Wells Fargo & Company San Francisco, CA44Shares$540.0% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $9.03M